Navigation Links
The Carpal Solution

ProductsThe Carpal Solution
Company First Hand Medical
Item The Carpal Solution
Features 
  • The Carpal Solution gently tugs simultaneously at three key points on the palm surrounding the carpal tunnel during sleep. Consistent gentle pulling action applied for 6 to 8 hours while the hand is relaxed, decompresses and reshapes the soft tissue around the carpal tunnel relieving pressure on the Median Nerve.
  • Carpal Solution combines this patented gentle soft tissue reshaping method during sleep with active use during the day. This results in an ideal rhythmic therapy for rapid relief from Carpal Tunnel Syndrome symptoms with no muscle atrophy or down time. The hand rehabilitates through normal use once pain is relieved.
  • The Carpal Solution has been shown to enhance blood circulation to the hand. Dr. Morgan suggests that increased nutrient and oxygen rich blood circulation reinvigorates the hand naturally and helps contribute to rapid recovery.
  • The Carpal Solution is specially designed to have an elasticity which matches the same basic elasticity found in ones skin, muscles and connective fascia tissue, allowing it to work in harmony with the bodys natural ability to stretch and relieve unwanted pressure and allow improved circulation in and around the Carpal Tunnel.
Description The Carpal Solution offers relief from CTS pain and hand tingling in days. It is different from other over-the-counter CTS treatments. It is not a rigid immobilizing brace. Worn during sleep, the Carpal Solution gently reshapes soft tissue in and around the Carpal Tunnel and eliminates hand pain, numbness and sleep interruption. It allows people to get back to their active life styles.
Info First Hand Medical
Customer Service: (781) 418-6340
Web site: http://www.mycarpaltunnel.com

Related medicine products :

1. Endoscopic Carpal Tunnel Release System
2. The Endotrac™ System For Endoscopic Carpal Tunnel Releases (ECTR)
3. Diamond Carpal Fusion Plates with System Pack Technology
4. Swanson Titanium Carpal Lunate Implants
5. Swanson Titanium Carpal Scaphoid Implant
6. MicroAire Carpal Tunnel Release System
7. ReNu MultiPlus Multi-Purpose Solution
8. Renu Multi-Purpose Solution
9. Opti-One Multi-Purpose Solution
10. Solo-Care Brand Multipurpose Solution
11. Sensitive Eyes Plus Saline Solution
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products:
(Date:11/25/2009)...swire/--WhenmostpeopleheartheacronymTMJ,theythinko...hehelptheyneed.TMJstandsfortheTemporal-MandibularJ...swithyourskull(temporalbone). ,, Themostcommons...ing,clickingorpoppingofthejaw.Butmanyothersymptoms...atigue,sleepdisturbances,irritability,alossinfocus...
(Date:11/25/2009)...leMedicalInc.,aleadingmanufacturerofbreastMRIcoils...wleadingedgeclinicalapplicationsonitsAegis(TM)medi...SocietyofNorthAmerica(RSNA)annualmeetinginChicago,...leveragetheuniquehighqualityimagesgeneratedbySenti...eimagingmodalitiesformulti-parametricassessment. ,...
(Date:11/25/2009)...eBayAreaAirQualityManagementDistrictisissuingthese... forThursday,November26,2009whichbansburningwood...rsandoutdoors. ,, "Cold,stillweatherwillcontrib...t,executiveofficeroftheAirDistrict."We,reaskingBay...fellowcommunitymembersthisThanksgiving,andnottobur...
(Date:11/25/2009)... a collaboration between UCLA engineers and physic... million Americans who suffer from peripheral arte...he arteries, peripheral arterial disease, or PAD, ...arteries reduce blood flow to the limbs. The condi..., heart attack and stroke, and its progression can...
(Date:11/25/2009)...eatment clinics to resume Monday, Nov. 30 , ...2009 -- Centegra Health System is continuing to of...four Centegra Primary Care (CPC) vaccination clini...The clinics are at CPC sites in Huntley, Woodstock...lows: ,   From 4:30 to 7:30 p.m. Tuesd...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...NTO, Calif., Feb. 20 CUREXO Technology Corporatio... image-directed robotic products for orthopaedic a...otic system, announced today that it has submitted... Surgical System for Total Knee Arthroplasty (TKA)...
... Calif., Feb. 25 Already a leader in the High T... Brand Intelligence software, is now offering its ...panies. , , Stu Clifton, New Momentum CEO, repo...twice the pace of legitimate pharmaceuticals -- an...
...ip anchor made from bioabsorbable Hydroxyapatite (...ew,s (NYSE: SNN ; LSE: SN) Endoscopy Division ha...or repair in the hip and shoulder. The device is s...rm an estimated 15,000 labral repair procedures in...
...gests jobs such as baby-sitting, lawn mowing could...lthDay News) -- A new study suggests it,s possible...juvenile delinquent. , Researchers found that fift...gs don,t prove that overwork directly leads to tro...
...turing efforts include the re-alignment of shared ...lishment of Pharmaceutical Governance and Medical ...nd PRINCETON, N.J., Feb. 25 Otsuka America Pharma...he North American pharmaceutical organizations, on...
... Feb. 25 The patent expiry of blockbuster molecul...confronting intense competition from generics. CEO...ative approaches to maintain the growth of their o...ter drugs represents a potential strategy that can...
Other Medicine News:Health News:CUREXO Technology Corporation Announces 510(k) Submission to FDA for Total Knee Arthroplasty Application 2Health News:New Momentum Launches Anti-Counterfeiting Software for Pharmaceutical Companies 2Health News:Smith & Nephew Endoscopy's OSTEORAPTOR(TM) Anchor Provides Bioabsorbable Solution for Labral Tears in the Hip and Shoulder 2Health News:Smith & Nephew Endoscopy's OSTEORAPTOR(TM) Anchor Provides Bioabsorbable Solution for Labral Tears in the Hip and Shoulder 3Health News:Smith & Nephew Endoscopy's OSTEORAPTOR(TM) Anchor Provides Bioabsorbable Solution for Labral Tears in the Hip and Shoulder 4Health News:Work May Not Be Best for Young Kids 2Health News:Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. Announce Restructuring Changes Aimed at Growing Otsuka's Pharmaceutical Business Worldwide 2Health News:Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. Announce Restructuring Changes Aimed at Growing Otsuka's Pharmaceutical Business Worldwide 3Health News:Market for Niche Blockbusters Promises an Attractive Future for Large Pharmaceutical Companies, Indicates Frost & Sullivan 2Health News:Market for Niche Blockbusters Promises an Attractive Future for Large Pharmaceutical Companies, Indicates Frost & Sullivan 3Health News:Market for Niche Blockbusters Promises an Attractive Future for Large Pharmaceutical Companies, Indicates Frost & Sullivan 4
(Date:11/25/2009)...e/-- ChemoCentryx,Inc.,announcedtodaythatPhaseII/...ctiveRandomizedOralTherapyEvaluationinCrohn,sdisea...oderate-to-severeCrohn,sdiseasedemonstratedclinica...e.Thestudydemonstratedevidenceofclinicalefficacyin...ecreaseintheCrohn,sDiseaseActivityIndex(CDAI)inpat...
(Date:11/24/2009)..., WHAT:RomHoubens,aBelgianmanthoughttohavebeeninco...lyconsciousandawakeduringthattimeandwasthesubjecto...turedinthesegmenttoillustratehowpeoplewithLocked-i... ,, WHEN:GoodMorningAmerica-- Tuesday,November2..., WHO:RomHoubenswasanengineeringstudentin1986when...
(Date:11/24/2009)...Call/--QuestDiagnosticsIncorporated(NYSE: DGX ),th...tionandservices,announcedthatitisscheduledtospeaka...wYorkCity.ThepresentationisscheduledforWednesday,D...econference,thecompanywillreaffirmits2009guidancef...ceed18%ofrevenues,anddilutedearningspersharefromco...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 1 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 2 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 3 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 4 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 5 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 6AlphaHelix Presents AmpXpress 28TM 29 at the BIOTECHNICA Show 14356 1AlphaHelix Presents AmpXpress 28TM 29 at the BIOTECHNICA Show 14356 2US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 1US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 2US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 3